Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 32,778 | -6,836 | -184,339 | -138,826 | -59,391 |
| Depreciation Amortization | 8,711 | 9,097 | 15,026 | 10,526 | 10,310 |
| Accounts receivable | -9,768 | -5,670 | -1,254 | -250 | -1,783 |
| Accounts payable and accrued liabilities | 891 | -3,578 | 2,880 | -2,587 | 657 |
| Other Working Capital | -5,707 | -26,920 | 2,102 | 28,635 | 15,399 |
| Other Operating Activity | 31,963 | 18,029 | 35,353 | 21,411 | -22,542 |
| Operating Cash Flow | $58,868 | $-15,878 | $-130,232 | $-81,091 | $-57,350 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | 1,004 | 3,436 | 0 | -1,705 |
| PPE Investments | -731 | -53 | -1,739 | -3,149 | -1,532 |
| Purchase Of Investment | N/A | N/A | -4,440 | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | N/A | 1,705 |
| Purchase Sale Intangibles | -4,000 | -6,000 | -21,225 | 10,150 | N/A |
| Other Investing Activity | -1,412 | -7,075 | -9,199 | 8,486 | 25 |
| Investing Cash Flow | $-2,143 | $-6,124 | $-11,942 | $5,337 | $-1,507 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 5,524 | 416 | 1,268 | 2,191 |
| Debt Issued | 48,427 | 0 | 38,538 | N/A | N/A |
| Debt Repayment | -127,828 | 0 | -504 | N/A | N/A |
| Common Stock Issued | 62,408 | 7,170 | 25,682 | 98,483 | 10 |
| Other Financing Activity | -10,533 | 0 | 0 | 0 | 114,990 |
| Financing Cash Flow | $-27,526 | $12,694 | $64,132 | $99,751 | $117,191 |
| Beginning Cash Position | 15,595 | 24,903 | 102,945 | 78,948 | 20,614 |
| End Cash Position | 44,794 | 15,595 | 24,903 | 102,945 | 78,948 |
| Net Cash Flow | $29,199 | $-9,308 | $-78,042 | $23,997 | $58,334 |
| Free Cash Flow | |||||
| Operating Cash Flow | 58,868 | -15,878 | -130,232 | -81,091 | -57,350 |
| Capital Expenditure | -731 | -53 | -1,739 | -3,149 | -1,682 |
| Free Cash Flow | 58,137 | -15,931 | -131,971 | -84,240 | -59,032 |